Lonza posts double-digit growth in H1 thanks to strong pharma demand
Lonza’s recent building spree and contracts have the manufacturer looking positive as it enters the second half of the year.
According to Lonza’s financial report …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.